How Abbott Laboratories stacks up

ABT · against 24 other Healthcare companies of similar size

Overall

45/ 100

Near the bottom of its peers.

Ranked #22 of 25 · scores higher than 8% of peers

Bars: peers in each 10-point band of the overall score

5 peers with an overall score of 40–49, including ABT · Click a bar to see the companies

The four scores behind it

Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)

Valuation#18 of 25Score 57 / 100 · beats 29%Growth#22 of 25Score 26 / 100 · beats 8%Profitability#18 of 25Score 68 / 100 · beats 21%Risk#12 of 25Higher relative risk · safety 30 · beats 54%

Ranking by overall score

Top 5 and the companies ranked around ABT

Rank	Company	Market cap	Overall	Valuation	Growth	Profitability	Risk
1	Novo Nordisk A/SNVO · US-listed	177.5B USD	71	92	60	99	2 / 2
2	Vertex Pharmaceuticals IncorporatedVRTX · US-listed	134.5B USD	70	55	58	96	0 / 2
3	Regeneron Pharmaceuticals, Inc.REGN · US-listed	100.2B USD	68	61	49	85	0 / 2
4	GSK plcGSK · US-listed	97.5B USD	67	87	72	89	2 / 2
5	SanofiSNY · US-listed	108.6B USD	66	88	55	72	1 / 2
⋯
18	Danaher CorporationDHR · US-listed	161.8B USD	50	53	47	68	2 / 2
19	CVS Health CorporationCVS · US-listed	116.9B USD	47	70	49	44	2 / 2
19	Thermo Fisher Scientific Inc.TMO · US-listed	258.2B USD	47	53	44	71	2 / 2
19	UnitedHealth Group IncorporatedUNH · US-listed	363.0B USD	47	65	38	61	2 / 2
22	Abbott LaboratoriesABT · US-listed	189.3B USD	45	57	26	68	2 / 2
22	Pfizer Inc.PFE · US-listed	171.0B USD	45	66	14	68	2 / 2
24	Merck & Co., Inc.MRK · US-listed	356.9B USD	37	54	20	55	2 / 2
25	Gilead Sciences, Inc.GILD · US-listed	207.7B USD	18	8	26	30	2 / 2

Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score

Bringing the fundamentals into focus…